Blog

A large-cap global pharmaceutical company with an immunology portfolio used Captario SUM® to understand what assets to prioritize within...

A large-cap global pharma company with a robust, diversified portfolio used Captario SUM® to model portfolio launch behavior over time...

Since its founding in 2012, Captario has never been the traditional company where ”you go to the office.” While there is a physical...

One method of illustrating risk is to show the value at risk (VaR). Plotting the fifth percentile from the simulated outputs in the left...

What challenges do pharmaceutical companies make regarding portfolio decisions? The portfolio elements are high-risk, expensive, take a...

At Captario, we continuously explore risk and return metrics for R&D portfolio assets, and we strive to stay on top of the many excellent...

Drug development is a risky business. Development products carry technical and regulatory risks (PTRS), operational risks (delays and...

Overall, everything in an organization, and especially a profit driven organization, is possible to quantify. If you have a tough...

This is a short story of when I was away from home in a city I had never been to before. I had been away all day, and all that was left...